Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
OBJECTIVES: To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. DESIGN: Open label, randomised, parallel group, phase II study. SETTING: Five...
主要な著者: | Waddington, C, Walker, W, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P, Allen, R, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A, Heath, P, Finn, A, Faust, SN, Snape, MD, Miller, E, Pollard, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2010
|
類似資料
-
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
著者:: Andrews, N, 等
出版事項: (2011) -
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
著者:: Andrews, N, 等
出版事項: (2011) -
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
著者:: Andrews, N, 等
出版事項: (2011) -
Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
著者:: Waddington, C, 等
出版事項: (2010) -
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
著者:: CS Waddington, 等
出版事項: (2010-10-01)